Apparently our friends at the Centers for Medicare and Medicaid Services (CMS) have misunderstood the details of the D recommendation about PSA screening for prostate cancer issued by the U.S. Preventive Services Task Force (USPSTF) in 2012, … READ MORE …
Filed under: Diagnosis, Risk | Tagged: CMS, Medicare, policy, PSA, screening | 4 Comments »
The American Society of Clinical Oncology (ASCO) has just published its first-ever policy statement on obesity and cancer, and is warning that “obesity could soon become the leading cause of cancer” here in America. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Prevention, Risk | Tagged: ASCO, education, obesity, policy, risk | 1 Comment »
On June 5 we had noted that, the day before, the American Society for Radiation Oncology (ASTRO) released its model policy on the use of proton beam radiation therapy (PBRT) and related reimbursement issues. … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: ASTRO, PBRT, policy, proton beam, radiation | 7 Comments »
According to a “model policy” statement just issued by the American Society for Radiation Oncology (ASTRO), reimbursement for costs related to the treatment of prostate cancer with proton beam radiation therapy (PBRT) should come with some very specific requirements. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: PBRT, policy, proton, reimbursement, therapy | 1 Comment »
The Prostate Cancer Roundtable has just announced an update to its national policy agenda — to include a focus on the importance of patient-reported outcomes data affecting quality of life in trials designed with survival as the primary endpoint. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: agenda, endpoint, outcome, patient-reported, policy, quality of life, Roundtable, trial | Leave a comment »
The Prostate Cancer Roundtable has announced an update to its policy agenda for 2013, concurrent with the start of the work of the new Congress here in the USA. … READ MORE …
Filed under: Uncategorized | Tagged: advocacy, Congress, policy, Roundable | 3 Comments »
Here in the USA, the two main organizations representing the primary care community ( the American College of Physicians [ACP] and the American Academy of Family Physicians [AAFP]) have taken no specific position on early detection and screening for prostate cancer since the ACP issued a now “inactive” guideline in 1997. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: early detection, guideline, policy, screening | 1 Comment »
It has taken a while to get there but the Prostate Cancer Roundtable finally has its own web site up and running. This will make it a good deal easier for people to keep up to date with the shared advocacy agenda and related activities of the major, US-based, patient-centric prostate cancer organizations. … READ MORE …
Filed under: Uncategorized | Tagged: advocacy, policy, Roundtable | Leave a comment »
According to a media release this morning the French national health authority (HAS) has put in place a special temporary reimbursement policy that will cover the use of high intensity focused ultrasound (HIFU) only for selected uses of this technique in the management of prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: France, HIFU, policy, reimbursement | 2 Comments »
According to a media release issued yesterday, “the members of the Prostate Cancer Roundtable have updated their shared, national policy agenda” which will act as the basis for discussions with U.S. policy makers in 2011 and beyond. … READ MORE …
Filed under: Uncategorized | Tagged: agenda, policy, Roundtable | 7 Comments »
On December 23, the National Cancer Institute (NCI) issued a media release announcing a first step toward major changes in how big, cooperative clinical trials get managed and funded in the USA. … READ MORE …
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: clinical trials, cooperative, National Cancer Institute, policy, process | Leave a comment »
Over the next few days, hundreds of prostate cancer patients, advocates, and researchers will be gathering in DC for a series of events focused on progress against prostate cancer. And there is a shared five-point plan of action to take to Congress and the White House. … READ MORE …
Filed under: Uncategorized | Tagged: advocacy, policy, research | Leave a comment »
Apparently the Centers for Medicare and Medicaid Services (CMS) rescinded the “least costly alternative” policy on April 19 this year. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: LCA, least costly alternative, policy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 